1324 related articles for article (PubMed ID: 21143139)
21. Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.
Cobourne-Duval MK; Taka E; Mendonca P; Soliman KFA
J Neuroimmunol; 2018 Jul; 320():87-97. PubMed ID: 29759145
[TBL] [Abstract][Full Text] [Related]
22. The role of microglial P2X7: modulation of cell death and cytokine release.
He Y; Taylor N; Fourgeaud L; Bhattacharya A
J Neuroinflammation; 2017 Jul; 14(1):135. PubMed ID: 28716092
[TBL] [Abstract][Full Text] [Related]
23. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
24. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
[TBL] [Abstract][Full Text] [Related]
25. Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia.
Siddiqui TA; Lively S; Schlichter LC
J Neuroinflammation; 2016 Mar; 13(1):66. PubMed ID: 27009332
[TBL] [Abstract][Full Text] [Related]
26. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
[TBL] [Abstract][Full Text] [Related]
27. Ca(2+) spiking activity caused by the activation of store-operated Ca(2+) channels mediates TNF-α release from microglial cells under chronic purinergic stimulation.
Ikeda M; Tsuno S; Sugiyama T; Hashimoto A; Yamoto K; Takeuchi K; Kishi H; Mizuguchi H; Kohsaka SI; Yoshioka T
Biochim Biophys Acta; 2013 Dec; 1833(12):2573-2585. PubMed ID: 23830920
[TBL] [Abstract][Full Text] [Related]
28. Microglial activation and its implications in the brain diseases.
Dheen ST; Kaur C; Ling EA
Curr Med Chem; 2007; 14(11):1189-97. PubMed ID: 17504139
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS.
Illes P; Rubini P; Ulrich H; Zhao Y; Tang Y
Cells; 2020 Apr; 9(5):. PubMed ID: 32365642
[TBL] [Abstract][Full Text] [Related]
30. CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia.
Milton RH; Abeti R; Averaimo S; DeBiasi S; Vitellaro L; Jiang L; Curmi PM; Breit SN; Duchen MR; Mazzanti M
J Neurosci; 2008 Nov; 28(45):11488-99. PubMed ID: 18987185
[TBL] [Abstract][Full Text] [Related]
31. Microglia and neuroprotection: from in vitro studies to therapeutic applications.
Polazzi E; Monti B
Prog Neurobiol; 2010 Nov; 92(3):293-315. PubMed ID: 20609379
[TBL] [Abstract][Full Text] [Related]
32. Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target.
Natunen TA; Gynther M; Rostalski H; Jaako K; Jalkanen AJ
Basic Clin Pharmacol Toxicol; 2019 Jan; 124(1):40-49. PubMed ID: 29998529
[TBL] [Abstract][Full Text] [Related]
33. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.
Zheng H; Liu Q; Zhou S; Luo H; Zhang W
Front Immunol; 2024; 15():1345625. PubMed ID: 38370420
[TBL] [Abstract][Full Text] [Related]
34. The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro.
Schlichter LC; Kaushal V; Moxon-Emre I; Sivagnanam V; Vincent C
J Neuroinflammation; 2010 Jan; 7():4. PubMed ID: 20074365
[TBL] [Abstract][Full Text] [Related]
35. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
[TBL] [Abstract][Full Text] [Related]
36. ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats.
Ortega FJ; Gimeno-Bayon J; Espinosa-Parrilla JF; Carrasco JL; Batlle M; Pugliese M; Mahy N; Rodríguez MJ
Exp Neurol; 2012 May; 235(1):282-96. PubMed ID: 22387180
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
38. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
39. Tetramethylpyrazine, a natural alkaloid, attenuates pro-inflammatory mediators induced by amyloid β and interferon-γ in rat brain microglia.
Kim M; Kim SO; Lee M; Lee JH; Jung WS; Moon SK; Kim YS; Cho KH; Ko CN; Lee EH
Eur J Pharmacol; 2014 Oct; 740():504-11. PubMed ID: 24975095
[TBL] [Abstract][Full Text] [Related]
40. Astrocyte-neuron interaction in the substantia gelatinosa of the spinal cord dorsal horn via P2X7 receptor-mediated release of glutamate and reactive oxygen species.
Ficker C; Rozmer K; Kató E; Andó RD; Schumann L; Krügel U; Franke H; Sperlágh B; Riedel T; Illes P
Glia; 2014 Oct; 62(10):1671-86. PubMed ID: 24895290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
